The BCPs in sotagliflozin-treated CF rabbits, reflected by the levels of K+, Ca2+, triglycerides, cholesterol, ALT, and TPRO, were significantly improved compared with those of the CF animals without sotagliflozin (Table 1). This evidence concerns the gene GPT and cystic fibrosis.